Skip to main content

Progeny 3, Inc.

SEC CIK
0001536006
Latest filing
Aug 14, 2026

ASND holding history

Ascendis Pharma A/S in every 13F filed by Progeny 3, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ASND overviewAll 13F holders of ASNDFull Q2 2026 holdings

Shares (Q2 2026)
5,230
Value
$1.39M
% of portfolio
0.1%
Quarters held
3
Since Q4 2025
Holdings of ASND by Progeny 3, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,230$1.39M0.1%00.0%UnchangedHolders
Q1 20265,230$1.20M0.1%00.0%UnchangedHolders
Q4 20255,230$1.12M0.1%+5,230NewHolders